Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study

M. Mego, R. A. Huddart, J. Voortman, M. Ong, C. Gedye, H. Gurney, A. P. Fay, A. Bamias, B. Mellado Gonzalez, Y. Loriot, A. S. Merseburger, D. Castellano Gauna, S. de Ducla, J. Pavlova, S. Fear, C. N. Sternberg

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S591-S591
JournalAnnals of Oncology
Publication statusPublished - Sept 2020

Cite this